Effect of bupivacaine versus bupivacaine plus intrathecal dexmedetomidine in postoperative pain
Prensa méd. argent
; 105(8): 443-447, sept 2019. tab
Artículo
en Inglés
| BINACIS, LILACS
| ID: biblio-1023260
Biblioteca responsable:
AR392.1
ABSTRACT
Background:
Pain is defined as "unpleasant sensory and sensory experience", associated with actual or potential tissue domage or described in terms of such damage. Objetive To assess the effect of bupivacaine versus bupivacaine plus intrathecal dexmedetomidine in postoperative pain. Patients andmethod:
An experimental design was made of a controlled clinical trial type, in patients scheduled for lower abdomen surgery or lower extremities. A sample of 60 patients was studied during the period from October 1 to december 15, 2018, who agreed to participate in the study through of signing consent under information.Results:
It was observed that the time of the rescue analgesia was prolonged in more than 120 min in the case of dexmedetomidine when compared with bupivacaine (p<0.0001); also VAS scores at the time of analgesia rescue for the group with dexmedetomidine were 3.71 ± 1.27 and in the bupivacaine group of 5.7 ± 1.59, the difference of two pints of the VAS (p= <0.001) was significant, which demonstrates that dexmedetomidine is effective for prolong postoperative analgesia and decrease the analgesia requirements.Conclusions:
Dexmedetomidine at a dose of 5 ug associated with bupivacaine administered intrathecally is more Effective in postoperative analgesia compared with this substance alone in abdominal surgery inferior and lower extremities (AU)
Colección:
Bases de datos internacionales
Base de datos:
BINACIS
/
LILACS
Asunto principal:
Dolor Postoperatorio
/
Dimensión del Dolor
/
Inyecciones Espinales
/
Bupivacaína
/
Estadísticas no Paramétricas
/
Dexmedetomidina
Tipo de estudio:
Ensayo clínico controlado
Límite:
Humanos
Idioma:
Inglés
Revista:
Prensa méd. argent
Asunto de la revista:
Medicina
Año:
2019
Tipo del documento:
Artículo